1H magnetic resonance spectroscopy evidence that aberrant crypt foci are preneoplastic lesions in the colon

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 1699-1703

  Krupnik, Eduardo ^a,b   Brière, Kathleen M ^a   Bird, Ranjana P ^b   Littman, Charles ^b   Smith, Ian C P ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Aberrant crypt foci; ACF; Colon cancer; Multivariate analysis; Rat

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CLASSIFICATION; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; CRYPT CELL; GENETIC ANALYSIS; HISTOPATHOLOGY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ANIMAL; CHEMICALLY INDUCED DISORDER; COLON DISEASE; COLON TUMOR; DISEASE COURSE; DRUG EFFECT; GERMFREE ANIMAL; INTESTINE MUCOSA; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

AZOXYMETHANE; LIPID;

ANIMALS; AZOXYMETHANE; COLONIC DISEASES; COLONIC NEOPLASMS; DISEASE PROGRESSION; INTESTINAL MUCOSA; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0345493903     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Weinberg RA: Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 49: 3713-3721, 1989.
2. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
3. MacLellan EA and Bird RP: Aberrant crypt foci: potential preneoplastic lesions in the murine colon. Cancer Res 48: 6187-6192, 1988.
4. Bird RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Letts 37: 147-151, 1987.
5. Pretlow TP Barrow BJ Ashton WS O'Riordan MA Pretlow TG Jurcisek JA and Stellato TA: Aberrant Crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 51: 1564-1567, 1991.
6. McLellan EA Medline A and Bird RP: Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res 51: 5270-5274, 1991.
7. Stopera SA and Bird RP: Expression of ras oncogene mRNA and protein in aberrant crypt foci. Carcinogenesis 13: 1863-1868, 1992.
8. Smith AJ Stern HS Penner M Hay K Mitri A Bapat BV and Gallinger S: Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54: 5527-5530, 1994.
9. Russell P Lean CL Delbridge L May GL, Dowd S and Mountford CE: Proton magnetic resonance and human thyroid neoplasia I: Discrimination between benign and malignant neoplasms. Amer J Med 96: 383-388, 1994.
10. 1H magnetic resonance spectroscopy of colon tissue. Anticancer Res 16: 1553-1558, 1996.
11. Smith ICP, Princz EJ and Saunders JK: Magnetic resonance spectroscopy in cancer research. J Can Assoc Radiol 41: 32-38, 1990.
12. 1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethylenglycol absorption in tumors may have diagnostic significance. NMR Biomed 6: 111-118, 1993.
13. 1H MR visible lipids in colon tissue from normal and carcinogen-treated rats. NMR Biomed 8: 33-40, 1995.
14. 1H spectra of thyroid neoplasms. Mag Reson Med 33: 257-263, 1995.
15. Kuesel AC, Kroft T, Saunders JK, Préfontaine M, Mikhael N and Smith ICP: A simple procedure for obtaining high-quality NMR spectra of semiquantitative value from small tissue specimens. Magn Reson Med 27: 340-355, 1992.
16. Nikulin A, Brière KM, Friesen L, Smith ICP and Somorjai RL: Genetic algorithm-guided optimal attribute selection: a novel preprocessor for classifying MR spectra. Proc Soc Magn Reson 3: 1940, 1995.